Under the development agreement, DiaSorin is responsible for commercialization of the Liaison LymeDetect while Qiagen and DiaSorin are jointly responsible for development and production of the solution.
Qiagen, 800-426-8157
DiaSorin, +39 0161 487.1
Pages: 1 2